Literature DB >> 11378874

Single-voxel oversampled J-resolved spectroscopy of in vivo human prostate tissue.

M G Swanson1, D B Vigneron, T K Tran, N Sailasuta, R E Hurd, J Kurhanewicz.   

Abstract

Single-voxel J-resolved spectroscopy with oversampling in the F1 dimension was used to obtain water unsuppressed 1H spectra of in situ human prostate tissue in 40 previously untreated prostate cancer patients. Based on T2-weighted MRI and previous biopsy information, voxels were placed in regions of benign or malignant peripheral zone tissue, or in regions of predominantly glandular or stromal benign prostatic hyperplasia (BPH) within the central gland. The addition of a second J-resolved dimension allowed for the observation of the J-modulation of citrate, as well as the resolution of polyamines from overlapping choline and creatine signals. Regions of healthy peripheral zone tissue and glandular BPH all demonstrated high levels of citrate and polyamines, with consistent coupling and J-modulation patterns. Conversely, regions of malignant peripheral zone tissue and stromal BPH demonstrated low levels of citrate and polyamines consistent with prior in vivo and ex vivo studies. Moreover, water T2 relaxation times determined for healthy peripheral zone tissue (mean 128 +/- 15.2 msec) were significantly different than for malignant peripheral zone tissue (mean 88.0 +/- 14.2 msec, P = 0.005), as well as for predominantly glandular (mean 92.4 +/- 12.2 msec, P = 0.009) and stromal BPH (mean 70.9 +/- 12.1 msec, P = 0.003). This preliminary study demonstrates that J-resolved spectroscopy of the in situ prostate can be acquired, and the information obtained from the second spectral dimension can provide additional physiologic information from human prostate tissue in a reasonable amount of time (< 10 min). Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378874     DOI: 10.1002/mrm.1130

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  9 in total

1.  Fast multivoxel two-dimensional spectroscopic imaging at 3 T.

Authors:  Dong-Hyun Kim; Roland Henry; Daniel M Spielman
Journal:  Magn Reson Imaging       Date:  2007-04-05       Impact factor: 2.546

2.  Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo.

Authors:  M Albert Thomas; Thomas Lange; S Sendhil Velan; Rajakumar Nagarajan; Steve Raman; Ana Gomez; Daniel Margolis; Stephany Swart; Raymond R Raylman; Rolf F Schulte; Peter Boesiger
Journal:  MAGMA       Date:  2008-07-17       Impact factor: 2.310

3.  Magnetic resonance imaging for prostate cancer clinical application.

Authors:  Bing Li; Yong Du; Hanfeng Yang; Yayong Huang; Jun Meng; Dongmei Xiao
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

4.  Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.

Authors:  Darko Pucar; Amita Shukla-Dave; Hedvig Hricak; Chaya S Moskowitz; Kentaro Kuroiwa; Semra Olgac; Lanie E Ebora; Peter T Scardino; Jason A Koutcher; Kristen L Zakian
Journal:  Radiology       Date:  2005-06-21       Impact factor: 11.105

5.  Multi-spin-echo J-resolved spectroscopic imaging without water suppression: application to a rat glioma at 7 T.

Authors:  G Hérigault; S Zoula; C Rémy; M Décorps; A Ziegler
Journal:  MAGMA       Date:  2004-10-26       Impact factor: 2.310

Review 6.  Advances in MR spectroscopy of the prostate.

Authors:  John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

Review 7.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.

Authors:  John Kurhanewicz; Mark G Swanson; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

Review 8.  Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches.

Authors:  Risto A Kauppinen; Andrew C Peet
Journal:  Cancer Biol Ther       Date:  2011-10-15       Impact factor: 4.742

9.  Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.

Authors:  Guro F Giskeødegård; Helena Bertilsson; Kirsten M Selnæs; Alan J Wright; Tone F Bathen; Trond Viset; Jostein Halgunset; Anders Angelsen; Ingrid S Gribbestad; May-Britt Tessem
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.